| Product NDC: | 53157-123 |
| Proprietary Name: | Leukotrap - CP2D Solution |
| Non Proprietary Name: | Anticoagulant Citrate Phosphate Double Dextrose |
| Active Ingredient(s): | 3.57 g/70mL & nbsp; Anticoagulant Citrate Phosphate Double Dextrose |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 53157-123 |
| Labeler Name: | Haemonetics Manufacturing Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA820915 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19831109 |
| Package NDC: | 53157-123-01 |
| Package Description: | 6 BAG in 1 POUCH (53157-123-01) > 70 mL in 1 BAG (53157-123-00) |
| NDC Code | 53157-123-01 |
| Proprietary Name | Leukotrap - CP2D Solution |
| Package Description | 6 BAG in 1 POUCH (53157-123-01) > 70 mL in 1 BAG (53157-123-00) |
| Product NDC | 53157-123 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Anticoagulant Citrate Phosphate Double Dextrose |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19831109 |
| Marketing Category Name | NDA |
| Labeler Name | Haemonetics Manufacturing Inc |
| Substance Name | DEXTROSE |
| Strength Number | 3.57 |
| Strength Unit | g/70mL |
| Pharmaceutical Classes |